U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07295769) titled 'Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause' on Nov. 26.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of a wearable device in detecting previously undiagnosed atrial fibrillation through non-invasive long-term monitoring using a wearable single-lead ECG patch (MEMO Patch M, MEMO Patch2) in 100 patients with Embolic Stroke of Undetermined Source (ESUS) who require atrial fibrillation screening. Participants who meet all inclusion and exclusion criteria and provide written informed consent will wear the MEMO Patch M and undergo in-hospital telemetry monitor...